Koppers
KOP
43.41
-0.83
-1.88%
Koppers
US · KOP
#3391 by market cap
43.41
-0.83
-1.88%
Live - 5344 symbols - heartbeat 111s ago
· 2026-10-09 19:30
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.44, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -10.17% YoY
Margins
- Gross margin
- 23.83%
- Operating margin
- 11.67%
- Net margin
- 2.98%
Key ratios & quality
- Enterprise valuei
- 1.73B
- Altman Z-Scorei
- 2.44
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.56B | 1.64B | 1.67B | 1.68B | 1.98B | 2.15B | 2.09B | 1.88B |
| Gross profit | 301.80M | 330.70M | 360.40M | 334.10M | 344.60M | 424.50M | 422.60M | 447.80M |
| Selling & admin expenses | 158.20M | 148.30M | 143.10M | 148.90M | 153.30M | 174.10M | 179.30M | 154.90M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 96.70M | 131.00M | 163.20M | 127.50M | 135.20M | 193.40M | 175.80M | 219.30M |
| Pretax profit | 31.20M | 63.70M | 110.10M | 119.60M | 95.40M | 124.60M | 69.30M | 81.20M |
| Tax | 25.70M | 0 | 21.00M | 34.50M | 31.60M | 34.80M | 20.70M | 25.20M |
| Net profit | 29.20M | 67.40M | 121.00M | 84.90M | 63.20M | 89.80M | 48.60M | 56.00M |
| Basic EPS | 1 | 3 | 6 | 4 | 3 | 4 | 3 | 3 |
| Diluted EPS | 1.10 | 3.16 | 5.71 | 3.88 | 2.98 | 4.14 | 2.46 | 2.74 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 456.50M | 504.80M | 485.30M | 432.70M | 455.30M | 520.10M |
| Gross profit | 105.80M | 114.20M | 117.00M | 110.80M | 86.60M | 109.00M |
| Selling & admin expenses | 41.10M | 39.50M | 37.50M | 36.80M | 41.70M | 40.90M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 46.70M | 56.70M | 61.90M | 54.00M | 25.50M | 50.20M |
| Pretax profit | -17.20M | 23.90M | 35.80M | 38.70M | 7.90M | -180.00M |
| Tax | -3.30M | 7.50M | 12.00M | 9.00M | 800.00K | -32.50M |
| Net profit | -13.90M | 16.40M | 23.80M | 29.70M | 7.10M | -147.50M |
| Basic EPS | -1 | 1 | 1 | 2 | 0 | -8 |
| Diluted EPS | -0.68 | 0.81 | 1.17 | 1.47 | 0.35 | -7.71 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 540.30M | 519.50M | 564.50M | 628.10M | 636.80M | 699.00M | 680.60M | 668.70M |
| Cash & ST investments | 40.60M | 32.30M | 38.50M | 45.50M | 33.30M | 66.50M | 43.90M | 38.00M |
| Inventory | 284.70M | 288.50M | 295.80M | 313.80M | 355.70M | 395.70M | 404.60M | 411.20M |
| Total assets | 1.48B | 1.56B | 1.60B | 1.66B | 1.71B | 1.84B | 1.89B | 1.89B |
| Total current liabilities | 298.70M | 296.20M | 292.10M | 285.70M | 324.00M | 325.90M | 325.80M | 227.10M |
| Short-term debt | 11.60M | 32.20M | 31.30M | 23.30M | 20.50M | 27.90M | 31.60M | 32.10M |
| Long-term debt | 978.80M | 891.00M | 765.80M | 781.50M | 817.70M | 835.40M | 925.90M | 914.30M |
| Total liabilities | 1,412,900,000.00 | 1,405,900,000.00 | 1,252,600,000.00 | 1,251,100,000.00 | 1,308,400,000.00 | 1,332,500,000.00 | 1,401,200,000.00 | 1,312,500,000.00 |
| Total equity | 67.00M | 158.70M | 346.00M | 410.80M | 403.00M | 503.00M | 489.00M | 574.30M |
| Retained earnings | 27.20M | 93.80M | 215.80M | 300.90M | 360.20M | 444.00M | 490.30M | 539.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 691.80M | 708.00M | 682.80M | 668.70M | 668.90M | 679.60M |
| Cash & ST investments | 33.30M | 38.40M | 37.90M | 38.00M | 42.80M | 40.70M |
| Inventory | 403.40M | 405.40M | 400.30M | 411.20M | 395.90M | 385.70M |
| Total assets | 1.89B | 1.93B | 1.89B | 1.89B | 1.88B | 1.72B |
| Total current liabilities | 262.20M | 272.30M | 259.80M | 227.10M | 246.50M | 291.40M |
| Short-term debt | 31.60M | 31.60M | 32.20M | 32.10M | 33.00M | 33.60M |
| Long-term debt | 975.90M | 962.90M | 918.30M | 914.30M | 915.30M | 892.70M |
| Total liabilities | 1,392,500,000.00 | 1,403,700,000.00 | 1,348,900,000.00 | 1,312,500,000.00 | 1,330,800,000.00 | 1,335,300,000.00 |
| Total equity | 498.30M | 527.10M | 545.90M | 574.30M | 549.50M | 387.00M |
| Retained earnings | 474.50M | 489.30M | 511.40M | 539.40M | 544.30M | 395.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 78.30M | 115.30M | 127.10M | 103.00M | 102.30M | 146.10M | 119.40M | 122.50M |
| Depreciation & amortization | 50.80M | 55.10M | 54.10M | 57.70M | 56.10M | 57.00M | 67.50M | 73.60M |
| Free cash flow | -31.40M | 78.10M | 57.30M | -22.00M | -3.00M | 25.60M | 42.00M | 67.50M |
| Dividends paid | -- | -- | 0 | 0 | -4.20M | -5.00M | -5.90M | -6.40M |
| Stock buybacks / issuance | -28.90M | 3.10M | -500.00K | -9.10M | -22.50M | -10.20M | -45.50M | -36.80M |
| Ending cash balance | 37.40M | 32.30M | 38.50M | 45.50M | 33.30M | 66.50M | 43.90M | 38.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -22.70M | 50.50M | 49.60M | 45.10M | 46.30M | 50.00M |
| Depreciation & amortization | 18.00M | 18.00M | 17.60M | 20.00M | 19.40M | 17.90M |
| Free cash flow | -37.00M | 38.40M | 37.60M | 28.50M | 34.90M | 37.70M |
| Dividends paid | -1.60M | -1.60M | -1.50M | -1.70M | -2.20M | -1.60M |
| Stock buybacks / issuance | -18.80M | -9.80M | -3.60M | -4.60M | -28.90M | -14.50M |
| Ending cash balance | 33.30M | 38.40M | 37.90M | 38.00M | 42.80M | 40.70M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 29.98 | 65.45 | 49.90 | 22.77 | 15.73 | 19.86 | 10.61 | 10.54 |
| ROA %i | 1.75 | 4.38 | 7.71 | 5.23 | 3.76 | 5.03 | 2.81 | 2.97 |
| ROIC %i | 7.07 | 11.57 | 13.56 | 9.08 | 7.22 | 10.27 | 7.20 | 6.54 |
| 5-year avg ROE %i | 52.09 | 70.59 | 136.49 | 42.55 | 36.77 | 34.74 | 23.77 | 15.90 |
| EBIT margin %i | 6.50 | 7.41 | 9.53 | 9.54 | 7.08 | 9.08 | 6.95 | 7.84 |
| FCF / sales %i | -- | 4.41 | 3.43 | -- | -- | 1.19 | 2.01 | 3.59 |
| Current ratioi | 1.81 | 1.75 | 1.93 | 2.20 | 1.97 | 2.14 | 2.09 | 2.94 |
| Quick ratioi | 0.78 | 0.66 | 0.73 | 0.80 | 0.77 | 0.83 | 0.72 | 0.87 |
| Debt / assetsi | 66.92 | 64.85 | 54.95 | 52.66 | 52.85 | 50.71 | 54.06 | 54.19 |
| LT debt / equityi | 1,741.64 | 667.01 | 247.91 | 209.49 | 221.33 | 180.96 | 202.64 | 172.54 |
| Interest coveragei | 1.97 | 2.10 | 3.25 | 3.95 | 3.13 | 2.75 | 1.91 | 2.23 |
| Revenue CAGR (3Y) %i | -1.33 | 4.95 | 4.20 | 2.41 | 6.56 | 8.88 | 7.62 | -1.73 |
| Net income CAGR (3Y) %i | -- | 31.48 | 61.25 | 53.84 | -1.63 | -9.91 | -14.96 | -4.05 |
| FCF CAGR (3Y) %i | -- | 3.92 | 18.66 | -- | -- | -23.55 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.08 | 2.92 | 2.99 | 10.54 | 14.70 | -19.02 |
| ROA %i | 1.37 | 0.78 | 0.84 | 2.97 | 4.08 | -4.76 |
| ROIC %i | 4.81 | 4.54 | 4.44 | 6.54 | 7.88 | -2.11 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.38 | 4.72 | 5.03 | 7.84 | 9.09 | -1.87 |
| FCF / sales %i | 2.13 | 3.61 | 4.94 | 3.59 | 7.42 | 7.33 |
| Current ratioi | 2.64 | 2.60 | 2.63 | 2.94 | 2.71 | 2.33 |
| Quick ratioi | 0.91 | 0.92 | 0.89 | 0.87 | 0.91 | 0.85 |
| Debt / assetsi | 56.55 | 55.39 | 54.26 | 54.19 | 54.40 | 58.15 |
| LT debt / equityi | 208.35 | 197.02 | 182.55 | 172.54 | 180.15 | 250.13 |
| Interest coveragei | 1.46 | 1.30 | 1.40 | 2.23 | 2.65 | -0.57 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Railroad and Utility Products and Services is the largest reported line at 47.28% of revenue, across 4 reported segments.
- Performance Chemicals follows at 33.97%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Railroad and Utility Products and Services47.28%
Performance Chemicals33.97%
Carbon Materials and Chemicals25.78%
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Koppers discussion 0 comments